People with systemic lupus erythematosus are more likely to have autoantibodies against post-translationally modified proteins than healthy controls, and these antibodies are associated with neuropsychiatric manifestations, researchers report in RMD Open.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.